Skip to main content
All lobbying filings

Illumina, Inc.

Illumina, Inc. filed a Q1 amendment for Illumina, Inc. on May 8, 2025.

Lobbying for Illumina, Inc.

As filed: ILLUMINA, INC. for ILLUMINA, INC.

All filings by Illumina, Inc. · Everything Illumina, Inc. has reported

 Filing · LD-2 quarterly report Q1 amendment
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted May 8, 2025
Expenses
$620,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
California

Official filing document

 Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 3

H.R.1968: Full-Year Continuing Appropriations and Extensions Act, 2025; all provisions

Discussions related to National Institutes of Health funding Discussions related to Laboratory Developed Tests (LDTs) regulation

Discussions related to Disease Detection

 Bills named in this filing 1
  • H.R. 1968
    Full-Year Continuing Appropriations and Extensions Act, 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem